Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease
- PMID: 3197979
- PMCID: PMC1433993
- DOI: 10.1136/gut.29.10.1332
Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease
Abstract
The rate of spinal trabecular bone loss during one year was measured in 54 patients with inflammatory bowel disease. The mean change in spinal bone mineral content was -5.1 mg/ml K2HPO4, representing 3% of the initial bone mineral content. The rate of bone loss showed a significant negative correlation with body mass index (r = -0.276, p less than 0.05) but no other significant correlations were found with other clinical or biochemical indices, including the total amount of prednisolone taken during the course of the study. Eleven patients had bone loss greater than 15 mg/ml/year; these included four non-steroid treated patients, two of whom had disease confined to the large bowel. The results indicate rapid rates of bone loss in some patients with inflammatory bowel disease over the course of one year. Although steroid therapy and malnutrition are likely to be contributory factors in some patients, other, as yet unidentified, risk factors also operate. The rapid bone loss observed in some patients emphasises the need for effective prophylactic regimes.
Similar articles
-
Osteoporosis in patients with inflammatory bowel disease.Gut. 1987 Apr;28(4):410-5. doi: 10.1136/gut.28.4.410. Gut. 1987. PMID: 3583068 Free PMC article.
-
Total body calcium in patients with inflammatory bowel disease: a longitudinal study.Clin Sci (Lond). 1991 Apr;80(4):319-24. doi: 10.1042/cs0800319. Clin Sci (Lond). 1991. PMID: 1851067
-
[Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].Z Gastroenterol. 1999 Jan;37(1):5-12. Z Gastroenterol. 1999. PMID: 10091278 German.
-
Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.Minerva Med. 2004 Dec;95(6):469-80. Minerva Med. 2004. PMID: 15785432 Review.
-
Skeletal morbidity in inflammatory bowel disease.Scand J Gastroenterol Suppl. 2006;(243):59-64. doi: 10.1080/00365520600664276. Scand J Gastroenterol Suppl. 2006. PMID: 16782623 Review.
Cited by
-
Persistently Elevated C-Reactive Protein Levels and Low Body Mass Index Are Associated with a Lack of Improvement in Bone Mineral Density in Crohn's Disease.Nutrients. 2024 Aug 23;16(17):2827. doi: 10.3390/nu16172827. Nutrients. 2024. PMID: 39275145 Free PMC article.
-
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.Gut. 2000 Feb;46(2):176-81. doi: 10.1136/gut.46.2.176. Gut. 2000. PMID: 10644310 Free PMC article.
-
Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.Dig Dis Sci. 2008 Oct;53(10):2746-53. doi: 10.1007/s10620-008-0223-0. Epub 2008 Mar 20. Dig Dis Sci. 2008. PMID: 18351466
-
Improvement of lumbar bone mass after infliximab therapy in Crohn's disease patients.Can J Gastroenterol. 2007 Oct;21(10):637-42. doi: 10.1155/2007/216162. Can J Gastroenterol. 2007. PMID: 17948133 Free PMC article.
-
Longitudinal study of bone mineral density in patients with Crohn's disease.Dig Dis Sci. 2003 Jul;48(7):1355-9. doi: 10.1023/a:1024171529000. Dig Dis Sci. 2003. PMID: 12870795
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical